Do analysts recommend QNRX or MLSS?

Milestone Scientific has a consensus price target of $1.00, suggesting a potential upside of 110.97%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Milestone Scientific is more favorable than Quoin Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quoin Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Does the media prefer QNRX or MLSS?

In the previous week, Milestone Scientific had 1 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 2 mentions for Milestone Scientific and 1 mentions for Quoin Pharmaceuticals. Quoin Pharmaceuticals' average media sentiment score of 0.00 equaled Milestone Scientific'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quoin Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Milestone Scientific 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend QNRX or NSPR?

InspireMD has a consensus price target of $4.50, indicating a potential upside of 533.80%. Given InspireMD's stronger consensus rating and higher probable upside, analysts plainly believe InspireMD is more favorable than Quoin Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quoin Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 InspireMD 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Does the media prefer QNRX or NSPR?

In the previous week, InspireMD had 2 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 3 mentions for InspireMD and 1 mentions for Quoin Pharmaceuticals. InspireMD's average media sentiment score of 0.25 beat Quoin Pharmaceuticals' score of 0.00 indicating that InspireMD is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quoin Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InspireMD 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer QNRX or IINN?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quoin Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, QNRX or IINN?

Inspira Technologies OXY B.H.N. has higher revenue and earnings than Quoin Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Quoin Pharmaceuticals N/A N/A -$15.81M -$29.56 N/A Inspira Technologies OXY B.H.N. $289K 125.63 -$13.22M N/A N/A

Is QNRX or IINN more profitable?

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Quoin Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Quoin Pharmaceuticals N/A -489.85% -221.29% Inspira Technologies OXY B.H.N. N/A N/A N/A

Does the media prefer QNRX or IINN?

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 2 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Quoin Pharmaceuticals. Quoin Pharmaceuticals' average media sentiment score of 0.00 equaled Inspira Technologies OXY B.H.N.'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quoin Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate QTEX or QNRX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Quoin Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger valuation & earnings, QTEX or QNRX?

Inspira Technologies OXY B.H.N. has higher revenue and earnings than Quoin Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inspira Technologies OXY B.H.N. $289K 129.99 -$13.22M N/A N/A Quoin Pharmaceuticals N/A N/A -$15.81M -$29.56 N/A

Is QTEX or QNRX more profitable?

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Quoin Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Inspira Technologies OXY B.H.N. N/A N/A N/A Quoin Pharmaceuticals N/A -489.85% -221.29%

Does the media refer more to QTEX or QNRX?

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 2 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Quoin Pharmaceuticals. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.00 equaled Quoin Pharmaceuticals'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Quoin Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate QNRX or TELA?

TELA Bio has a consensus price target of $2.20, suggesting a potential upside of 139.39%. Given TELA Bio's stronger consensus rating and higher possible upside, analysts plainly believe TELA Bio is more favorable than Quoin Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quoin Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 TELA Bio 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Does the media refer more to QNRX or TELA?

In the previous week, TELA Bio had 2 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 3 mentions for TELA Bio and 1 mentions for Quoin Pharmaceuticals. Quoin Pharmaceuticals' average media sentiment score of 0.00 equaled TELA Bio'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quoin Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral TELA Bio 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Quoin Pharmaceuticals (QNRX) Competitors

$4.38 -0.07 (-1.60%)

As of 04:00 PM Eastern

Compare

QNRX vs. MLSS, NSPR, IINN, QTEX, and TELA

Should you buy Quoin Pharmaceuticals stock or one of its competitors? MarketBeat compares Quoin Pharmaceuticals with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Quoin Pharmaceuticals include Milestone Scientific (MLSS), InspireMD (NSPR), Inspira Technologies OXY B.H.N. (IINN), Inspira Technologies OXY B.H.N. (QTEX), and TELA Bio (TELA).

How does Quoin Pharmaceuticals compare to Milestone Scientific?

Quoin Pharmaceuticals (NASDAQ:QNRX) and Milestone Scientific (NYSE:MLSS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership.

In the previous week, Milestone Scientific had 1 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 2 mentions for Milestone Scientific and 1 mentions for Quoin Pharmaceuticals. Quoin Pharmaceuticals' average media sentiment score of 0.00 equaled Milestone Scientific'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quoin Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Milestone Scientific	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Quoin Pharmaceuticals has a beta of 1.49, meaning that its share price is 49% more volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market.

8.6% of Quoin Pharmaceuticals shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 11.2% of Quoin Pharmaceuticals shares are owned by insiders. Comparatively, 9.2% of Milestone Scientific shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Milestone Scientific has higher revenue and earnings than Quoin Pharmaceuticals. Milestone Scientific is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$29.56	N/A
Milestone Scientific	$8.90M	4.71	-$6.93M	-$0.05	N/A

Quoin Pharmaceuticals has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Milestone Scientific's return on equity of -60.26% beat Quoin Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quoin Pharmaceuticals	N/A	-489.85%	-221.29%
Milestone Scientific	-52.01%	-60.26%	-40.23%

Milestone Scientific has a consensus price target of $1.00, suggesting a potential upside of 110.97%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Milestone Scientific is more favorable than Quoin Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Milestone Scientific beats Quoin Pharmaceuticals on 8 of the 13 factors compared between the two stocks.

How does Quoin Pharmaceuticals compare to InspireMD?

Quoin Pharmaceuticals (NASDAQ:QNRX) and InspireMD (NYSE:NSPR) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends.

InspireMD has a consensus price target of $4.50, indicating a potential upside of 533.80%. Given InspireMD's stronger consensus rating and higher probable upside, analysts plainly believe InspireMD is more favorable than Quoin Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Quoin Pharmaceuticals has a beta of 1.49, meaning that its share price is 49% more volatile than the broader market. Comparatively, InspireMD has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market.

Quoin Pharmaceuticals has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Quoin Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quoin Pharmaceuticals	N/A	-489.85%	-221.29%
InspireMD	-413.96%	-69.42%	-57.68%

Quoin Pharmaceuticals has higher earnings, but lower revenue than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$29.56	N/A
InspireMD	$10.85M	3.07	-$19.92M	-$0.73	N/A

8.6% of Quoin Pharmaceuticals shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 11.2% of Quoin Pharmaceuticals shares are held by company insiders. Comparatively, 34.1% of InspireMD shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, InspireMD had 2 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 3 mentions for InspireMD and 1 mentions for Quoin Pharmaceuticals. InspireMD's average media sentiment score of 0.25 beat Quoin Pharmaceuticals' score of 0.00 indicating that InspireMD is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quoin Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
InspireMD	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

InspireMD beats Quoin Pharmaceuticals on 11 of the 15 factors compared between the two stocks.

How does Quoin Pharmaceuticals compare to Inspira Technologies OXY B.H.N.?

Quoin Pharmaceuticals (NASDAQ:QNRX) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

Inspira Technologies OXY B.H.N. has higher revenue and earnings than Quoin Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$29.56	N/A
Inspira Technologies OXY B.H.N.	$289K	125.63	-$13.22M	N/A	N/A

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 2 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Quoin Pharmaceuticals. Quoin Pharmaceuticals' average media sentiment score of 0.00 equaled Inspira Technologies OXY B.H.N.'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quoin Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

8.6% of Quoin Pharmaceuticals shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 11.2% of Quoin Pharmaceuticals shares are owned by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Quoin Pharmaceuticals has a beta of 1.49, indicating that its share price is 49% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its share price is 116% more volatile than the broader market.

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Quoin Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quoin Pharmaceuticals	N/A	-489.85%	-221.29%
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

Summary

Inspira Technologies OXY B.H.N. beats Quoin Pharmaceuticals on 8 of the 10 factors compared between the two stocks.

How does Quoin Pharmaceuticals compare to Inspira Technologies OXY B.H.N.?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and Quoin Pharmaceuticals (NASDAQ:QNRX) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership.

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 8.6% of Quoin Pharmaceuticals shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Comparatively, 11.2% of Quoin Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Quoin Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
Quoin Pharmaceuticals	N/A	-489.85%	-221.29%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Inspira Technologies OXY B.H.N. has a beta of 4.2, suggesting that its stock price is 320% more volatile than the broader market. Comparatively, Quoin Pharmaceuticals has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market.

Inspira Technologies OXY B.H.N. has higher revenue and earnings than Quoin Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$289K	129.99	-$13.22M	N/A	N/A
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$29.56	N/A

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 2 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Quoin Pharmaceuticals. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.00 equaled Quoin Pharmaceuticals'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Quoin Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Inspira Technologies OXY B.H.N. beats Quoin Pharmaceuticals on 8 of the 10 factors compared between the two stocks.

How does Quoin Pharmaceuticals compare to TELA Bio?

Quoin Pharmaceuticals (NASDAQ:QNRX) and TELA Bio (NASDAQ:TELA) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

TELA Bio has a consensus price target of $2.20, suggesting a potential upside of 139.39%. Given TELA Bio's stronger consensus rating and higher possible upside, analysts plainly believe TELA Bio is more favorable than Quoin Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Quoin Pharmaceuticals has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. Quoin Pharmaceuticals' return on equity of -489.85% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quoin Pharmaceuticals	N/A	-489.85%	-221.29%
TELA Bio	-49.30%	-1,320.81%	-55.83%

8.6% of Quoin Pharmaceuticals shares are owned by institutional investors. Comparatively, 94.4% of TELA Bio shares are owned by institutional investors. 11.2% of Quoin Pharmaceuticals shares are owned by company insiders. Comparatively, 5.1% of TELA Bio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Quoin Pharmaceuticals has higher earnings, but lower revenue than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$29.56	N/A
TELA Bio	$80.28M	0.51	-$38.83M	-$0.79	N/A

Quoin Pharmaceuticals has a beta of 1.49, meaning that its share price is 49% more volatile than the broader market. Comparatively, TELA Bio has a beta of 1.34, meaning that its share price is 34% more volatile than the broader market.

In the previous week, TELA Bio had 2 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 3 mentions for TELA Bio and 1 mentions for Quoin Pharmaceuticals. Quoin Pharmaceuticals' average media sentiment score of 0.00 equaled TELA Bio'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quoin Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
TELA Bio	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

TELA Bio beats Quoin Pharmaceuticals on 8 of the 14 factors compared between the two stocks.

Get Quoin Pharmaceuticals News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QNRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QNRX vs. The Competition

Export

Metric	Quoin Pharmaceuticals	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$8.67M	$11.45B	$6.80B	$13.02B
Dividend Yield	N/A	2.74%	2.60%	10.03%
P/E Ratio	-0.15	791.59	279.73	25.56
Price / Sales	N/A	948.13	649.61	116.36
Price / Cash	N/A	14.82	28.64	34.82
Price / Book	0.28	10.43	11.12	6.36
Net Income	-$15.81M	$2.81B	$3.48B	$347.58M
7 Day Performance	2.71%	1.93%	2.67%	3.24%
1 Month Performance	-5.81%	-3.06%	-2.70%	-2.00%
1 Year Performance	-36.37%	154.91%	64.43%	21.31%

Quoin Pharmaceuticals Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QNRX Quoin Pharmaceuticals	0.8187 of 5 stars	$4.31 -3.1%	N/A	-33.2%	$8.67M	N/A	N/A	4	Positive News Upcoming Earnings
MLSS Milestone Scientific	1.2126 of 5 stars	$0.38 -12.6%	$1.00 +166.0%	+1.0%	$33.26M	$8.90M	N/A	30	News Coverage Gap Up
NSPR InspireMD	3.7975 of 5 stars	$0.67 -1.8%	$4.50 +569.6%	-74.7%	$31.48M	$10.85M	N/A	50
IINN Inspira Technologies OXY B.H.N.	0.0434 of 5 stars	$0.87 -8.1%	N/A	-26.8%	$31.38M	$289K	N/A	20	Upcoming Earnings High Trading Volume
QTEX Inspira Technologies OXY B.H.N.	0.2942 of 5 stars	$0.85 -2.6%	N/A	N/A	$30.56M	$289K	N/A	20

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QNRX) was last updated on 8/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Quoin Pharmaceuticals (QNRX) Competitors

QNRX vs. MLSS, NSPR, IINN, QTEX, and TELA

How does Quoin Pharmaceuticals compare to Milestone Scientific?

Summary

How does Quoin Pharmaceuticals compare to InspireMD?

Summary

How does Quoin Pharmaceuticals compare to Inspira Technologies OXY B.H.N.?

Summary

How does Quoin Pharmaceuticals compare to Inspira Technologies OXY B.H.N.?

Summary

How does Quoin Pharmaceuticals compare to TELA Bio?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QNRX vs. The Competition

Quoin Pharmaceuticals Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Quoin Pharmaceuticals (QNRX) Competitors

QNRX vs. MLSS, NSPR, IINN, QTEX, and TELA

How does Quoin Pharmaceuticals compare to Milestone Scientific?

Does the media prefer QNRX or MLSS?

Which has more risk & volatility, QNRX or MLSS?

Do insiders & institutionals hold more shares of QNRX or MLSS?

Which has preferable earnings and valuation, QNRX or MLSS?

Is QNRX or MLSS more profitable?

Do analysts recommend QNRX or MLSS?

Summary

How does Quoin Pharmaceuticals compare to InspireMD?

Do analysts recommend QNRX or NSPR?

Which has more risk and volatility, QNRX or NSPR?

Is QNRX or NSPR more profitable?

Which has stronger earnings and valuation, QNRX or NSPR?

Do institutionals & insiders believe in QNRX or NSPR?

Does the media prefer QNRX or NSPR?

Summary

How does Quoin Pharmaceuticals compare to Inspira Technologies OXY B.H.N.?

Which has better valuation & earnings, QNRX or IINN?

Does the media prefer QNRX or IINN?

Do institutionals and insiders believe in QNRX or IINN?

Do analysts prefer QNRX or IINN?

Which has more risk and volatility, QNRX or IINN?

Is QNRX or IINN more profitable?

Summary

How does Quoin Pharmaceuticals compare to Inspira Technologies OXY B.H.N.?

Do institutionals & insiders hold more shares of QTEX or QNRX?

Is QTEX or QNRX more profitable?

Do analysts rate QTEX or QNRX?

Which has more risk & volatility, QTEX or QNRX?

Which has stronger valuation & earnings, QTEX or QNRX?

Does the media refer more to QTEX or QNRX?

Summary

How does Quoin Pharmaceuticals compare to TELA Bio?

Do analysts rate QNRX or TELA?

Is QNRX or TELA more profitable?

Do institutionals and insiders have more ownership in QNRX or TELA?

Which has higher valuation & earnings, QNRX or TELA?

Which has more risk and volatility, QNRX or TELA?

Does the media refer more to QNRX or TELA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QNRX vs. The Competition

Quoin Pharmaceuticals Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools